

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 8.20073664 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 8.13198064 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63804679 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 7.63804679 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.36798359 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.36798359 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.93301879 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.29379884 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.29379884 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.29379884 |
| 11 | glyoxylate metabolic process (GO:0046487) | 6.22380576 |
| 12 | ethanol metabolic process (GO:0006067) | 6.09744897 |
| 13 | kynurenine metabolic process (GO:0070189) | 6.01258605 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.95880543 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.93020324 |
| 16 | cysteine metabolic process (GO:0006534) | 5.77762350 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.77258125 |
| 18 | oxidative demethylation (GO:0070989) | 5.53296743 |
| 19 | urea metabolic process (GO:0019627) | 5.47513420 |
| 20 | urea cycle (GO:0000050) | 5.47513420 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.41098816 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 5.36108237 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 5.26572156 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 5.26374514 |
| 25 | lysine metabolic process (GO:0006553) | 5.25777331 |
| 26 | lysine catabolic process (GO:0006554) | 5.25777331 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 5.25260127 |
| 28 | blood coagulation, intrinsic pathway (GO:0007597) | 5.08609400 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 5.06090824 |
| 30 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.06009683 |
| 31 | aromatic amino acid family metabolic process (GO:0009072) | 5.05952408 |
| 32 | protein carboxylation (GO:0018214) | 5.03571021 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.03571021 |
| 34 | regulation of fibrinolysis (GO:0051917) | 5.02409793 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.96649369 |
| 36 | bile acid metabolic process (GO:0008206) | 4.89512731 |
| 37 | opsonization (GO:0008228) | 4.87070144 |
| 38 | complement activation, alternative pathway (GO:0006957) | 4.82737570 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.79330563 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.79096893 |
| 41 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.77035272 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.76980655 |
| 43 | alpha-amino acid catabolic process (GO:1901606) | 4.75781584 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.65319383 |
| 45 | cellular ketone body metabolic process (GO:0046950) | 4.64046093 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 4.57745374 |
| 47 | protein activation cascade (GO:0072376) | 4.57420984 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.57183188 |
| 49 | negative regulation of lipase activity (GO:0060192) | 4.54079510 |
| 50 | drug catabolic process (GO:0042737) | 4.52974239 |
| 51 | protein-lipid complex remodeling (GO:0034368) | 4.49226014 |
| 52 | macromolecular complex remodeling (GO:0034367) | 4.49226014 |
| 53 | plasma lipoprotein particle remodeling (GO:0034369) | 4.49226014 |
| 54 | S-adenosylmethionine metabolic process (GO:0046500) | 4.48051290 |
| 55 | negative regulation of sterol transport (GO:0032372) | 4.46471829 |
| 56 | negative regulation of cholesterol transport (GO:0032375) | 4.46471829 |
| 57 | regulation of complement activation (GO:0030449) | 4.46391880 |
| 58 | indolalkylamine metabolic process (GO:0006586) | 4.46043622 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 4.44511036 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.43037184 |
| 61 | complement activation (GO:0006956) | 4.42514322 |
| 62 | protein-lipid complex assembly (GO:0065005) | 4.41003000 |
| 63 | glutamate metabolic process (GO:0006536) | 4.40684386 |
| 64 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.38324695 |
| 65 | regulation of plasminogen activation (GO:0010755) | 4.38150314 |
| 66 | triglyceride homeostasis (GO:0070328) | 4.37190465 |
| 67 | acylglycerol homeostasis (GO:0055090) | 4.37190465 |
| 68 | cellular modified amino acid catabolic process (GO:0042219) | 4.35684847 |
| 69 | glycine metabolic process (GO:0006544) | 4.34328976 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.34165360 |
| 71 | amine catabolic process (GO:0009310) | 4.34165360 |
| 72 | urate metabolic process (GO:0046415) | 4.32301029 |
| 73 | phospholipid efflux (GO:0033700) | 4.30799027 |
| 74 | drug transmembrane transport (GO:0006855) | 4.30607317 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.29472646 |
| 76 | plasma lipoprotein particle organization (GO:0071827) | 4.29428965 |
| 77 | cellular glucuronidation (GO:0052695) | 4.24208847 |
| 78 | benzene-containing compound metabolic process (GO:0042537) | 4.23824209 |
| 79 | serine family amino acid biosynthetic process (GO:0009070) | 4.21959742 |
| 80 | complement activation, classical pathway (GO:0006958) | 4.16096360 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 4.14865122 |
| 82 | aldehyde catabolic process (GO:0046185) | 4.11294927 |
| 83 | bile acid and bile salt transport (GO:0015721) | 4.10450011 |
| 84 | exogenous drug catabolic process (GO:0042738) | 4.08317768 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 4.06723551 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 4.06467391 |
| 87 | phenylpropanoid metabolic process (GO:0009698) | 4.06382156 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.04315465 |
| 89 | protein-lipid complex subunit organization (GO:0071825) | 4.03515562 |
| 90 | ketone body metabolic process (GO:1902224) | 4.01658533 |
| 91 | arginine metabolic process (GO:0006525) | 4.00938755 |
| 92 | ethanol oxidation (GO:0006069) | 3.99761292 |
| 93 | acute-phase response (GO:0006953) | 3.98079282 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.94759393 |
| 95 | cytolysis (GO:0019835) | 3.92079104 |
| 96 | cholesterol efflux (GO:0033344) | 3.90329192 |
| 97 | negative regulation of hemostasis (GO:1900047) | 3.89137885 |
| 98 | negative regulation of blood coagulation (GO:0030195) | 3.89137885 |
| 99 | organic acid catabolic process (GO:0016054) | 3.88549459 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.88549459 |
| 101 | aspartate family amino acid catabolic process (GO:0009068) | 3.86701589 |
| 102 | cellular response to zinc ion (GO:0071294) | 3.86571747 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.84422067 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.84422067 |
| 105 | acetyl-CoA metabolic process (GO:0006084) | 3.83992837 |
| 106 | regulation of humoral immune response (GO:0002920) | 3.83482332 |
| 107 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.77521884 |
| 108 | fibrinolysis (GO:0042730) | 3.76967027 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 3.74847886 |
| 110 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.74497827 |
| 111 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.74497827 |
| 112 | 2-oxoglutarate metabolic process (GO:0006103) | 3.70251418 |
| 113 | low-density lipoprotein particle remodeling (GO:0034374) | 3.69344458 |
| 114 | flavonoid metabolic process (GO:0009812) | 3.68357486 |
| 115 | regulation of lipoprotein particle clearance (GO:0010984) | 3.65969397 |
| 116 | cofactor catabolic process (GO:0051187) | 3.65943241 |
| 117 | regulation of bile acid biosynthetic process (GO:0070857) | 3.65541108 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62011459 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62011459 |
| 120 | regulation of cholesterol homeostasis (GO:2000188) | 3.61845379 |
| 121 | drug transport (GO:0015893) | 3.60024920 |
| 122 | alkaloid metabolic process (GO:0009820) | 3.59769966 |
| 123 | cholesterol homeostasis (GO:0042632) | 3.59465030 |
| 124 | drug metabolic process (GO:0017144) | 3.58075335 |
| 125 | fatty acid oxidation (GO:0019395) | 3.57398329 |
| 126 | monocarboxylic acid catabolic process (GO:0072329) | 3.57267420 |
| 127 | carnitine metabolic process (GO:0009437) | 3.56836356 |
| 128 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.56661366 |
| 129 | fatty acid beta-oxidation (GO:0006635) | 3.56374306 |
| 130 | NAD biosynthetic process (GO:0009435) | 3.55722142 |
| 131 | sterol homeostasis (GO:0055092) | 3.55542425 |
| 132 | negative regulation of coagulation (GO:0050819) | 3.53221276 |
| 133 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.51981230 |
| 134 | regulation of lipoprotein metabolic process (GO:0050746) | 3.47718880 |
| 135 | regulation of triglyceride metabolic process (GO:0090207) | 3.44352904 |
| 136 | negative regulation of wound healing (GO:0061045) | 3.41108850 |
| 137 | regulation of cholesterol transport (GO:0032374) | 3.36242943 |
| 138 | regulation of sterol transport (GO:0032371) | 3.36242943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.37546370 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.16556024 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.74009314 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.42290287 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16506082 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.03157372 |
| 7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.86518355 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.93754529 |
| 9 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.82605593 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.18846857 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.17233982 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13703151 |
| 13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.13110430 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8497222 |
| 15 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.82629302 |
| 16 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.69996691 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60749415 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59660181 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56463241 |
| 20 | * SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.52503073 |
| 21 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.48394463 |
| 22 | P68_20966046_ChIP-Seq_HELA_Human | 1.48215720 |
| 23 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46221058 |
| 24 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.40779820 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39960894 |
| 26 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35965097 |
| 27 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.32562035 |
| 28 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30246582 |
| 29 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29371409 |
| 30 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29219827 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23666742 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22125103 |
| 33 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.22071639 |
| 34 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.19783902 |
| 35 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.17918564 |
| 36 | * RAC3_21632823_ChIP-Seq_H3396_Human | 1.17776023 |
| 37 | P300_27268052_Chip-Seq_Bcells_Human | 1.16278515 |
| 38 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.14473822 |
| 39 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.12520683 |
| 40 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11805766 |
| 41 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11181088 |
| 42 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07338292 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06856781 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05724464 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04197433 |
| 46 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03856483 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01486309 |
| 48 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00653888 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98593504 |
| 50 | ERA_21632823_ChIP-Seq_H3396_Human | 0.97050468 |
| 51 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.96960940 |
| 52 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96463887 |
| 53 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.95096307 |
| 54 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.94651495 |
| 55 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93662473 |
| 56 | SA1_27219007_Chip-Seq_Bcells_Human | 0.91741765 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91536478 |
| 58 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.91347407 |
| 59 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.89212231 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.88159573 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88044325 |
| 62 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87680101 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84439932 |
| 64 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84118148 |
| 65 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82149165 |
| 66 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.81069990 |
| 67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80499047 |
| 68 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.79361002 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.77981902 |
| 70 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77883307 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.77612450 |
| 72 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77591147 |
| 73 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77391919 |
| 74 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.76245576 |
| 75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74943017 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74881780 |
| 77 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73740042 |
| 78 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.73723437 |
| 79 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72590964 |
| 80 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.72247641 |
| 81 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72100425 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71258115 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.70831852 |
| 84 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.70524588 |
| 85 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.70123462 |
| 86 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.68931095 |
| 87 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.68759953 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.68698030 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.68639635 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68311323 |
| 91 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68186552 |
| 92 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67096425 |
| 93 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.66152105 |
| 94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.64810304 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.64589423 |
| 96 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.63484690 |
| 97 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62834262 |
| 98 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.62631131 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.61284233 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.60729562 |
| 101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60494633 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.59393292 |
| 103 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.57221968 |
| 104 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.57119254 |
| 105 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.57119254 |
| 106 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.56365455 |
| 107 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55972060 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54126079 |
| 109 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52590323 |
| 110 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51069427 |
| 111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50456868 |
| 112 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.49495419 |
| 113 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48040733 |
| 114 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47792872 |
| 115 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.46414957 |
| 116 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46003310 |
| 117 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.45840791 |
| 118 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45748017 |
| 119 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.45674942 |
| 120 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.45105464 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.45054105 |
| 122 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.44920705 |
| 123 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.44433357 |
| 124 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.44399082 |
| 125 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.44038176 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.43609656 |
| 127 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.42034891 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.41982832 |
| 129 | GATA2_19941826_ChIP-Seq_K562_Human | 0.41773781 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41710022 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.41013505 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.40940495 |
| 133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.40426381 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39512814 |
| 135 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.38143786 |
| 136 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.38005490 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37933592 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.37503901 |
| 139 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36922423 |
| 140 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36763282 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36486604 |
| 142 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.36380990 |
| 143 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.36185982 |
| 144 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36182235 |
| 145 | NCOR_22424771_ChIP-Seq_293T_Human | 0.36162985 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.28289549 |
| 2 | MP0005360_urolithiasis | 7.88467779 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15511900 |
| 4 | MP0005365_abnormal_bile_salt | 5.95956385 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.13284239 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.06043153 |
| 7 | MP0003252_abnormal_bile_duct | 3.81793506 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.37920396 |
| 9 | MP0005332_abnormal_amino_acid | 3.20824931 |
| 10 | MP0003195_calcinosis | 3.09063204 |
| 11 | MP0009840_abnormal_foam_cell | 3.08259905 |
| 12 | MP0005083_abnormal_biliary_tract | 2.80756839 |
| 13 | MP0004019_abnormal_vitamin_homeostasis | 2.59878330 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.49941411 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.35756057 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.29840525 |
| 17 | MP0000609_abnormal_liver_physiology | 2.05811193 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.03724084 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.86050830 |
| 20 | MP0003868_abnormal_feces_composition | 1.74420502 |
| 21 | MP0001764_abnormal_homeostasis | 1.71582426 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64998009 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.64448237 |
| 24 | MP0005451_abnormal_body_composition | 1.54865325 |
| 25 | MP0002132_abnormal_respiratory_system | 1.43456502 |
| 26 | MP0003186_abnormal_redox_activity | 1.41692582 |
| 27 | MP0005397_hematopoietic_system_phenotyp | 1.40038755 |
| 28 | MP0001545_abnormal_hematopoietic_system | 1.40038755 |
| 29 | MP0009697_abnormal_copulation | 1.33543127 |
| 30 | MP0005636_abnormal_mineral_homeostasis | 1.26161586 |
| 31 | MP0003011_delayed_dark_adaptation | 1.22485395 |
| 32 | MP0000598_abnormal_liver_morphology | 1.14369060 |
| 33 | MP0003656_abnormal_erythrocyte_physiolo | 1.13902722 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.09579995 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.05228523 |
| 36 | MP0009764_decreased_sensitivity_to | 1.05184333 |
| 37 | MP0000604_amyloidosis | 1.02816802 |
| 38 | MP0005647_abnormal_sex_gland | 1.02703012 |
| 39 | MP0001756_abnormal_urination | 0.94186386 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.93542783 |
| 41 | MP0009763_increased_sensitivity_to | 0.93198349 |
| 42 | MP0009278_abnormal_bone_marrow | 0.92526649 |
| 43 | MP0002876_abnormal_thyroid_physiology | 0.90780603 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.90213106 |
| 45 | MP0008469_abnormal_protein_level | 0.89098803 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.88579467 |
| 47 | MP0004043_abnormal_pH_regulation | 0.88274567 |
| 48 | MP0005670_abnormal_white_adipose | 0.85900265 |
| 49 | MP0002282_abnormal_trachea_morphology | 0.85488060 |
| 50 | MP0002254_reproductive_system_inflammat | 0.84956170 |
| 51 | MP0005408_hypopigmentation | 0.83584873 |
| 52 | MP0002136_abnormal_kidney_physiology | 0.78578108 |
| 53 | MP0010368_abnormal_lymphatic_system | 0.78186087 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.77409473 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.76880361 |
| 56 | MP0004233_abnormal_muscle_weight | 0.76167395 |
| 57 | MP0001986_abnormal_taste_sensitivity | 0.74989157 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 0.74752408 |
| 59 | MP0005535_abnormal_body_temperature | 0.74436785 |
| 60 | MP0003879_abnormal_hair_cell | 0.73666254 |
| 61 | MP0005377_hearing/vestibular/ear_phenot | 0.73019363 |
| 62 | MP0003878_abnormal_ear_physiology | 0.73019363 |
| 63 | MP0005220_abnormal_exocrine_pancreas | 0.70870600 |
| 64 | MP0001661_extended_life_span | 0.68780294 |
| 65 | MP0002971_abnormal_brown_adipose | 0.68176743 |
| 66 | MP0005187_abnormal_penis_morphology | 0.67803441 |
| 67 | MP0003329_amyloid_beta_deposits | 0.64539781 |
| 68 | MP0001881_abnormal_mammary_gland | 0.63903001 |
| 69 | MP0005334_abnormal_fat_pad | 0.62681713 |
| 70 | MP0003690_abnormal_glial_cell | 0.61295369 |
| 71 | MP0005266_abnormal_metabolism | 0.61147302 |
| 72 | MP0001765_abnormal_ion_homeostasis | 0.60547800 |
| 73 | MP0009053_abnormal_anal_canal | 0.59142946 |
| 74 | MP0004130_abnormal_muscle_cell | 0.59034105 |
| 75 | MP0004270_analgesia | 0.58656529 |
| 76 | MP0006035_abnormal_mitochondrial_morpho | 0.57750177 |
| 77 | MP0002332_abnormal_exercise_endurance | 0.57483647 |
| 78 | MP0002928_abnormal_bile_duct | 0.55259272 |
| 79 | MP0003638_abnormal_response/metabolism_ | 0.53016473 |
| 80 | MP0005395_other_phenotype | 0.51697058 |
| 81 | MP0005058_abnormal_lysosome_morphology | 0.49925811 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.49786649 |
| 83 | MP0005646_abnormal_pituitary_gland | 0.49199524 |
| 84 | MP0006292_abnormal_olfactory_placode | 0.46818062 |
| 85 | MP0005448_abnormal_energy_balance | 0.46743014 |
| 86 | MP0005666_abnormal_adipose_tissue | 0.45843100 |
| 87 | MP0002822_catalepsy | 0.44361452 |
| 88 | MP0008874_decreased_physiological_sensi | 0.44326721 |
| 89 | MP0005464_abnormal_platelet_physiology | 0.43621360 |
| 90 | MP0000230_abnormal_systemic_arterial | 0.43283100 |
| 91 | MP0003953_abnormal_hormone_level | 0.42822547 |
| 92 | MP0008873_increased_physiological_sensi | 0.41870490 |
| 93 | MP0004782_abnormal_surfactant_physiolog | 0.41700681 |
| 94 | MP0002168_other_aberrant_phenotype | 0.41460586 |
| 95 | MP0003724_increased_susceptibility_to | 0.41080983 |
| 96 | MP0002234_abnormal_pharynx_morphology | 0.41075670 |
| 97 | MP0003075_altered_response_to | 0.40852333 |
| 98 | MP0005409_darkened_coat_color | 0.40749462 |
| 99 | MP0003718_maternal_effect | 0.40326630 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.39380200 |
| 101 | MP0008872_abnormal_physiological_respon | 0.39361276 |
| 102 | MP0009672_abnormal_birth_weight | 0.39113121 |
| 103 | MP0002069_abnormal_eating/drinking_beha | 0.38269357 |
| 104 | MP0002837_dystrophic_cardiac_calcinosis | 0.37649193 |
| 105 | MP0002796_impaired_skin_barrier | 0.37587044 |
| 106 | MP0001905_abnormal_dopamine_level | 0.37103830 |
| 107 | MP0005166_decreased_susceptibility_to | 0.36847911 |
| 108 | MP0000538_abnormal_urinary_bladder | 0.34682630 |
| 109 | MP0005595_abnormal_vascular_smooth | 0.34039335 |
| 110 | MP0002135_abnormal_kidney_morphology | 0.33909293 |
| 111 | MP0000566_synostosis | 0.32869511 |
| 112 | MP0005330_cardiomyopathy | 0.32858164 |
| 113 | MP0002269_muscular_atrophy | 0.32831819 |
| 114 | MP0003436_decreased_susceptibility_to | 0.32792156 |
| 115 | MP0000516_abnormal_urinary_system | 0.31929713 |
| 116 | MP0005367_renal/urinary_system_phenotyp | 0.31929713 |
| 117 | MP0005375_adipose_tissue_phenotype | 0.31482222 |
| 118 | MP0009115_abnormal_fat_cell | 0.30478883 |
| 119 | MP0001915_intracranial_hemorrhage | 0.30164197 |
| 120 | MP0006082_CNS_inflammation | 0.30058663 |
| 121 | MP0001845_abnormal_inflammatory_respons | 0.28992742 |
| 122 | MP0002909_abnormal_adrenal_gland | 0.28236038 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.28125315 |
| 124 | MP0000249_abnormal_blood_vessel | 0.27395377 |
| 125 | MP0002970_abnormal_white_adipose | 0.27018905 |
| 126 | MP0005167_abnormal_blood-brain_barrier | 0.25384246 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.23413504 |
| 128 | MP0004883_abnormal_blood_vessel | 0.23280489 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.23180006 |
| 130 | MP0000579_abnormal_nail_morphology | 0.23157754 |
| 131 | MP0001243_abnormal_dermal_layer | 0.23112769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.28968370 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.77039256 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.75443508 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.34692565 |
| 5 | Xanthomatosis (HP:0000991) | 6.00296071 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.86482765 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.77690109 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.14880526 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.73004650 |
| 10 | Hyperammonemia (HP:0001987) | 4.69120798 |
| 11 | Complement deficiency (HP:0004431) | 4.66753076 |
| 12 | Ketosis (HP:0001946) | 4.54445072 |
| 13 | Hyperglycinuria (HP:0003108) | 4.49412834 |
| 14 | Hyperglycinemia (HP:0002154) | 4.48431020 |
| 15 | Joint hemorrhage (HP:0005261) | 4.47721406 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.36524530 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.36146415 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.33619756 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 4.30123716 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.30123716 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.09085094 |
| 22 | Epidermoid cyst (HP:0200040) | 4.06871493 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 3.98917344 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.97748822 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 3.87389775 |
| 26 | Fat malabsorption (HP:0002630) | 3.81375403 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77501715 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.77251543 |
| 29 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.61766674 |
| 30 | Gout (HP:0001997) | 3.57489967 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.47213320 |
| 32 | Ketoacidosis (HP:0001993) | 3.46044794 |
| 33 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39156733 |
| 34 | Abnormality of complement system (HP:0005339) | 3.36961325 |
| 35 | Delayed CNS myelination (HP:0002188) | 3.36274658 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 3.32069122 |
| 37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.30905925 |
| 38 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28480046 |
| 39 | Hypercholesterolemia (HP:0003124) | 3.24883877 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.19472637 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 3.13142685 |
| 42 | Abnormality of iron homeostasis (HP:0011031) | 3.08037789 |
| 43 | Increased serum ferritin (HP:0003281) | 3.05013755 |
| 44 | Nephritis (HP:0000123) | 3.02071253 |
| 45 | Metabolic acidosis (HP:0001942) | 3.00370791 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.97044126 |
| 47 | Microvesicular hepatic steatosis (HP:0001414) | 2.88512021 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.86544865 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.86544865 |
| 50 | Steatorrhea (HP:0002570) | 2.86309418 |
| 51 | Vascular calcification (HP:0004934) | 2.86190532 |
| 52 | Lethargy (HP:0001254) | 2.80213280 |
| 53 | Neonatal hypoglycemia (HP:0001998) | 2.79782024 |
| 54 | Generalized aminoaciduria (HP:0002909) | 2.69787733 |
| 55 | Spontaneous abortion (HP:0005268) | 2.64947430 |
| 56 | Myocardial infarction (HP:0001658) | 2.62367508 |
| 57 | Proximal tubulopathy (HP:0000114) | 2.59232167 |
| 58 | Alkalosis (HP:0001948) | 2.58348889 |
| 59 | Hypochromic microcytic anemia (HP:0004840) | 2.57544134 |
| 60 | Cardiovascular calcification (HP:0011915) | 2.53657399 |
| 61 | Cerebral edema (HP:0002181) | 2.53248260 |
| 62 | Increased purine levels (HP:0004368) | 2.52287159 |
| 63 | Hyperuricemia (HP:0002149) | 2.52287159 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.52070499 |
| 65 | Irritability (HP:0000737) | 2.51330173 |
| 66 | Neonatal onset (HP:0003623) | 2.50530085 |
| 67 | Spastic diplegia (HP:0001264) | 2.50407364 |
| 68 | Skin nodule (HP:0200036) | 2.47678400 |
| 69 | Malnutrition (HP:0004395) | 2.47083262 |
| 70 | Enlarged kidneys (HP:0000105) | 2.36053048 |
| 71 | Vomiting (HP:0002013) | 2.35978827 |
| 72 | Fair hair (HP:0002286) | 2.31691948 |
| 73 | Abnormality of proline metabolism (HP:0010907) | 2.29737935 |
| 74 | Hydroxyprolinuria (HP:0003080) | 2.29737935 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.29262580 |
| 76 | Mitral stenosis (HP:0001718) | 2.28729407 |
| 77 | Sensorimotor neuropathy (HP:0007141) | 2.27757098 |
| 78 | Pigmentary retinal degeneration (HP:0001146) | 2.26353271 |
| 79 | Rickets (HP:0002748) | 2.25227139 |
| 80 | Purpura (HP:0000979) | 2.24610925 |
| 81 | Late onset (HP:0003584) | 2.24160276 |
| 82 | Abnormal gallbladder morphology (HP:0012437) | 2.20601140 |
| 83 | Abnormality of urine glucose concentration (HP:0011016) | 2.19451949 |
| 84 | Glycosuria (HP:0003076) | 2.19451949 |
| 85 | Glomerulonephritis (HP:0000099) | 2.19067849 |
| 86 | Pancreatitis (HP:0001733) | 2.18255776 |
| 87 | Cholelithiasis (HP:0001081) | 2.16772919 |
| 88 | Acanthocytosis (HP:0001927) | 2.15963461 |
| 89 | Seborrheic dermatitis (HP:0001051) | 2.15650217 |
| 90 | Reduced antithrombin III activity (HP:0001976) | 2.13468437 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.08481146 |
| 92 | Cholecystitis (HP:0001082) | 2.08481146 |
| 93 | Amyloidosis (HP:0011034) | 2.07514476 |
| 94 | Brushfield spots (HP:0001088) | 2.05699401 |
| 95 | Abnormality of the Achilles tendon (HP:0005109) | 2.05331245 |
| 96 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.04561855 |
| 97 | Opisthotonus (HP:0002179) | 2.03009745 |
| 98 | Esophageal varix (HP:0002040) | 2.02804411 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00444027 |
| 100 | Hypochromic anemia (HP:0001931) | 1.99000829 |
| 101 | Hypophosphatemic rickets (HP:0004912) | 1.98684287 |
| 102 | Thrombophlebitis (HP:0004418) | 1.98623457 |
| 103 | Menorrhagia (HP:0000132) | 1.97889304 |
| 104 | Hyperphosphaturia (HP:0003109) | 1.91458231 |
| 105 | Abnormal cartilage morphology (HP:0002763) | 1.90367547 |
| 106 | Gingival bleeding (HP:0000225) | 1.89292739 |
| 107 | Back pain (HP:0003418) | 1.87911600 |
| 108 | Abnormality of the gallbladder (HP:0005264) | 1.86844145 |
| 109 | Nephrolithiasis (HP:0000787) | 1.86625104 |
| 110 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.83927460 |
| 111 | Hemorrhage of the eye (HP:0011885) | 1.83696794 |
| 112 | Confusion (HP:0001289) | 1.83273940 |
| 113 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82781218 |
| 114 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81225838 |
| 115 | Megaloblastic anemia (HP:0001889) | 1.80239718 |
| 116 | Cerebral palsy (HP:0100021) | 1.77811797 |
| 117 | Stroke (HP:0001297) | 1.71061275 |
| 118 | Epistaxis (HP:0000421) | 1.70840777 |
| 119 | Pulmonary embolism (HP:0002204) | 1.70174871 |
| 120 | Abnormality of vitamin metabolism (HP:0100508) | 1.65879490 |
| 121 | Joint swelling (HP:0001386) | 1.55517022 |
| 122 | Abnormal urine phosphate concentration (HP:0012599) | 1.52568038 |
| 123 | Hypertriglyceridemia (HP:0002155) | 1.51626923 |
| 124 | Retinal atrophy (HP:0001105) | 1.48768896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.64463741 |
| 2 | MUSK | 5.74258621 |
| 3 | FGFR4 | 4.44949406 |
| 4 | SIK1 | 4.05827966 |
| 5 | ERN1 | 4.01698900 |
| 6 | TESK2 | 3.72977986 |
| 7 | INSRR | 2.68514123 |
| 8 | PIM2 | 2.61178394 |
| 9 | TAOK3 | 2.52573366 |
| 10 | ERBB4 | 2.49041264 |
| 11 | MST1R | 2.18689228 |
| 12 | MAP2K4 | 2.10909477 |
| 13 | WNK4 | 2.05930743 |
| 14 | WNK3 | 2.00715227 |
| 15 | PKN2 | 2.00148426 |
| 16 | MAPK11 | 1.81040650 |
| 17 | TRIB3 | 1.73928756 |
| 18 | PTK2B | 1.73772949 |
| 19 | NME2 | 1.70335976 |
| 20 | FLT3 | 1.66957557 |
| 21 | PIK3CG | 1.58412636 |
| 22 | LMTK2 | 1.56806281 |
| 23 | STK38L | 1.55725775 |
| 24 | OXSR1 | 1.54230709 |
| 25 | OBSCN | 1.51298064 |
| 26 | ABL2 | 1.50302164 |
| 27 | TYK2 | 1.47335403 |
| 28 | ARAF | 1.43516915 |
| 29 | PTK6 | 1.42719427 |
| 30 | PINK1 | 1.40747441 |
| 31 | LATS1 | 1.40465255 |
| 32 | DAPK2 | 1.38047853 |
| 33 | GRK6 | 1.33527533 |
| 34 | FRK | 1.21072148 |
| 35 | KDR | 1.19318331 |
| 36 | MAP3K7 | 1.18919502 |
| 37 | NEK9 | 1.18143787 |
| 38 | TNK2 | 1.16228949 |
| 39 | MARK3 | 1.13835554 |
| 40 | JAK2 | 1.10792530 |
| 41 | FGFR2 | 1.10474608 |
| 42 | PRKAA2 | 1.09315197 |
| 43 | MAP2K3 | 1.06424986 |
| 44 | TBK1 | 1.05570971 |
| 45 | RPS6KA5 | 1.02658146 |
| 46 | CSNK1G2 | 0.97517781 |
| 47 | EPHB1 | 0.95707511 |
| 48 | CSNK1G3 | 0.94864491 |
| 49 | TESK1 | 0.94376611 |
| 50 | MAP3K3 | 0.93535532 |
| 51 | RPS6KC1 | 0.92574572 |
| 52 | RPS6KL1 | 0.92574572 |
| 53 | PRKCZ | 0.92142598 |
| 54 | MAP3K14 | 0.91435506 |
| 55 | TIE1 | 0.90400136 |
| 56 | CSNK1A1L | 0.88969735 |
| 57 | MAPK4 | 0.87862674 |
| 58 | RPS6KA6 | 0.87554350 |
| 59 | DYRK1B | 0.86567091 |
| 60 | IKBKB | 0.85976064 |
| 61 | MAP3K11 | 0.84982218 |
| 62 | ERBB2 | 0.84849436 |
| 63 | MAPK15 | 0.83080400 |
| 64 | MYLK | 0.82079917 |
| 65 | MET | 0.81621810 |
| 66 | GSK3A | 0.80766148 |
| 67 | SGK223 | 0.79885346 |
| 68 | SGK494 | 0.79885346 |
| 69 | MAP3K10 | 0.79666330 |
| 70 | SGK3 | 0.79529948 |
| 71 | PDK3 | 0.79414590 |
| 72 | PDK4 | 0.79414590 |
| 73 | JAK1 | 0.79101591 |
| 74 | PRKD2 | 0.78199113 |
| 75 | MAPK12 | 0.78013664 |
| 76 | MAP2K7 | 0.75597929 |
| 77 | CDK9 | 0.74509207 |
| 78 | PRKACG | 0.74480522 |
| 79 | PRPF4B | 0.72872884 |
| 80 | CDK19 | 0.71864252 |
| 81 | PRKAA1 | 0.70599276 |
| 82 | AKT2 | 0.69717524 |
| 83 | DYRK2 | 0.69181251 |
| 84 | TGFBR2 | 0.67962717 |
| 85 | KIT | 0.67850318 |
| 86 | MAP2K6 | 0.67771658 |
| 87 | PTK2 | 0.67356572 |
| 88 | DAPK3 | 0.65618111 |
| 89 | SGK2 | 0.65180330 |
| 90 | CDK6 | 0.64780644 |
| 91 | PDPK1 | 0.64245844 |
| 92 | CSK | 0.63092690 |
| 93 | CAMK2G | 0.62489554 |
| 94 | MAP2K2 | 0.61675531 |
| 95 | IRAK3 | 0.61353610 |
| 96 | NEK1 | 0.60773704 |
| 97 | RIPK1 | 0.56255335 |
| 98 | IKBKE | 0.51204664 |
| 99 | EPHA3 | 0.50815309 |
| 100 | JAK3 | 0.50475894 |
| 101 | EPHA4 | 0.49980054 |
| 102 | MAP3K1 | 0.49070006 |
| 103 | PRKACA | 0.47910830 |
| 104 | PRKCQ | 0.47329460 |
| 105 | CAMKK2 | 0.46095186 |
| 106 | RPS6KA2 | 0.45738152 |
| 107 | MAPK7 | 0.45348865 |
| 108 | CSF1R | 0.42159667 |
| 109 | CSNK1G1 | 0.41990113 |
| 110 | PIK3CA | 0.41589026 |
| 111 | NTRK3 | 0.41422230 |
| 112 | TAOK2 | 0.41411656 |
| 113 | CAMK1D | 0.41340726 |
| 114 | TAOK1 | 0.40587168 |
| 115 | PDK1 | 0.40467487 |
| 116 | PDK2 | 0.39294809 |
| 117 | IGF1R | 0.39049651 |
| 118 | PRKCG | 0.38669675 |
| 119 | FGFR3 | 0.38557183 |
| 120 | FER | 0.38082007 |
| 121 | STK39 | 0.37889853 |
| 122 | CSNK1A1 | 0.37437619 |
| 123 | GRK1 | 0.37403789 |
| 124 | STK38 | 0.36544571 |
| 125 | MAP2K1 | 0.35654161 |
| 126 | MAP3K5 | 0.34403453 |
| 127 | RPS6KA1 | 0.33718538 |
| 128 | MAPK3 | 0.33709423 |
| 129 | BCR | 0.33255638 |
| 130 | CSNK1D | 0.33081369 |
| 131 | DYRK3 | 0.33006269 |
| 132 | IRAK2 | 0.31582678 |
| 133 | CAMK4 | 0.31452639 |
| 134 | SIK2 | 0.31116696 |
| 135 | CDK4 | 0.30586705 |
| 136 | MTOR | 0.30048776 |
| 137 | MAP3K6 | 0.29903188 |
| 138 | PRKD1 | 0.29801988 |
| 139 | PRKACB | 0.29304097 |
| 140 | ICK | 0.28994046 |
| 141 | PRKCA | 0.28007827 |
| 142 | RET | 0.27865046 |
| 143 | EGFR | 0.27154761 |
| 144 | MAP3K13 | 0.26914324 |
| 145 | PKN1 | 0.26424402 |
| 146 | IRAK1 | 0.25224136 |
| 147 | PBK | 0.24545350 |
| 148 | PAK3 | 0.23424565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24528763 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.45473428 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33646858 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.32171125 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99016279 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77085435 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71861575 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61169809 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.57649300 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52996298 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51598445 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.47015047 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39677785 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.39175695 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.19354537 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.09162176 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07361417 |
| 18 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.89819061 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88046264 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.86021376 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85243835 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84992857 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82979324 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.82173319 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.77167974 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.73921852 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71149130 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69623193 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62787038 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.60453572 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59799906 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58558164 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54565508 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.53131017 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51979457 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.51892707 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.46039216 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.39892541 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.36904895 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.35800452 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.32958714 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.28934295 |
| 43 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28659035 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.25203898 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23642542 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.21887892 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.20376557 |
| 48 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14738248 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12089253 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.07669293 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07139481 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03876706 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.01425911 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96565616 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95189274 |
| 56 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93606643 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.87315660 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83922696 |
| 59 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81025759 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80213363 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76575426 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71988965 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70435599 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.69846574 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60003623 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49276659 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38459432 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32996243 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28637773 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24770412 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.22877565 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22513433 |
| 73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21197011 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.19799408 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.18504637 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.17894011 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.16498716 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11066188 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06535242 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00747920 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00275377 |
| 82 | Renin secretion_Homo sapiens_hsa04924 | -0.2389023 |
| 83 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | -0.2384193 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2322024 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | -0.2319937 |
| 86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2206769 |
| 87 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2102658 |
| 88 | Other glycan degradation_Homo sapiens_hsa00511 | -0.2092249 |
| 89 | Lysosome_Homo sapiens_hsa04142 | -0.2037113 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1994181 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1870296 |
| 92 | Hepatitis C_Homo sapiens_hsa05160 | -0.1817586 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1709906 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | -0.1563660 |
| 95 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1561634 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.1495771 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | -0.1477267 |
| 98 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.1470289 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1419155 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1383903 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1378873 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1334504 |
| 103 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1243038 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1033239 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0975093 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0957465 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0913766 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0800739 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0751291 |
| 110 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0566562 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.0321422 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0316622 |

